Amidst the carnage in the sector, as others bleed, horizon is like the cactus flower full of moisture in the harshest environment. People will begin to pay up for safety as they exit failed positions.
Exerpt from WSJ article today:
"The FDA isn’t likely to formally approve or reject the drug until next month, and the FDA stressed that, “It is important to recognize that no final conclusions have been reached on the approvability of this application.” But the documents suggest regulators are skeptical of the drug’s efficacy based on existing clinical data.
“Although FDA is prepared to be flexible with respect to a devastating illness with no treatment options, we cannot approve drugs for which substantial evidence of effectiveness has not been established.” The stock plunged more than 50% Friday morning.
The book isn’t closed on eteplirsen. Even if the FDA declines to approve the drug next month, a new phase 3 clinical trial is underway. That should be completed in 2018. Those results could satisfy the FDA’s concerns."
With IMO-8400 and DMD, does anyone here know how long it would take to get to a phase 3 and then how long that would take? Does 3GY lend itself to this disease as a potential combination therapy with a drug like eteplirsen?
These apparently were just notes released by FDA ahead of ADCOM which isn't until next week, so I read elsewhere. They haven't formally ditched the medicine eteplirsen, that would come in the form of a CRL after ADCOM. This is really a perfect setup for IDRA to come around the corner with IMO-8400 trial and show safety and disease modifying characteristics. Anyone know how long this trial would take? I think I recall they were targeting a start date of Q1.
Don't overlook the gap fill at 2043. Holding this week will either make or break the market. If we take out the August low of 1873, all bets are off on a contra-trend rally IMHO.
Loading the boat is dangerous, are you sure this is the right thing to do with fraud allegations and the loss of Stability as a customer? I am not invested here since $14, but did leave a pile of good capital here, I can only imagine what it must be like for you loyal longs? Really am sorry so many good people here are getting hurt by the indiscretions of management and now the hit piece.
Repeat, another 52 week low, happening all around, but this drop of almost 17% seems harsh. I left at $14, but I got my dividend!
I joined on with Ron Walker last night Bio, and watched yesterday the video online with Tom McClellan. The scenario seems correct, tired of being played.
Maybe today is capitulation, currently off 15%. Very disillusioned about this Company. Offering at 8.75, last year ran to 13's, now $3.02. Give it up, shorts should be banned, they are wrecking the sector.
Baker Brothers' largest position is INCY, where they own 19,474,939 shares. Since this rout started, that share price has dropped from $110 a share to $78 today (down $10 just today). This represents an impact to their portfolio value of $623,198,048. When I look at their portfolio, it makes me wonder how stressed they get, or if there is a danger of a cascading effect amongst funds that are so sector aligned. They must have very sophisticated money managers, at least I hope they do, plus significant cash resources. I know yesterday they put up $75,000M into ACAD's offering, at $29 a share. Today that closed at $23.32, down over $5 in one day. That is what I call max pain, we are just getting a taste.
I added 1,000 shares this morning at 3.66, silly me. I figure we may gap up in the morning with any kind of good opening. GL. PS your SGYP, you still awaiting buyout? Really think that's the end game?
"Should be a fun week" you said, but in hindsight, it's been a bio wreck, and I know what you meant, but OMG, it's decimated this sector. It can be rebuilt in a couple months, what they did to us in a week and a half, but now everybody's confidence is shattered. This is so cheap now it's embarrassing to management and try to explain it, you can't.
I'd be lurking as well, it's rare to pick up this much going on in the segment for so little, but it even got cheaper today. As Cramer would say BUY BUY BUY!
Trovagene needs some news like Biocept got yesterday.
More than eight million members gain access to Biocept's suite of blood-based diagnostics through agreement with Illinois' largest health plan, bringing total covered lives to approximately 133 million
SAN DIEGO , Jan. 12, 2016 /PRNewswire/ -- Biocept, Inc. ( NASDAQ : BIOC), a molecular diagnostics company commercializing and developing blood-based biomarkers to improve the detection and treatment of cancer, announces that it has entered into an agreement with Blue Cross Blue Shield of Illinois (BCBS IL) allowing its members access to Biocept's broad menu for liquid biopsy testing. With the addition of BCBS IL's more than eight million members, the number of patients with access to Biocept's liquid biopsy assays through their healthcare insurance plan has increased to approximately 133 million.
You're still here, was missing your posting. OK, it's one day, we've had a rout and anyone selling now is late, they know what they hold. 1.6 million shares were bought and sold, and 80,000 shares were bought in the last 5 minutes. Somebody waited all day to buy in, and it had been as high as 2.14, as low as 1.98. I'd say the day went to the longs. It's a victory, on the day of Milano's presentation, glad he was properly supported and not slammed.
Thank you for following up and doing this, you stand more to lose than any retail holder I know, he set us up for the bloodbath we took today. Didn't have to be this way, Chaim obviously doesn't know how to handle his role, that conference call was shamefully lightweight. Short sellers AF and others are having their way with the stock now, we holders are paying for it big time. Terrible.